AmplifyBio, LLC is a U.S.-based contract research and development organization focused on cell and gene therapies, including preclinical and translational research, bioanalytics, and related development services. It serves biotechnology and pharmaceutical companies developing advanced therapeutic products.
Subscribe to see AmplifyBio, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AmplifyBio, LLC is a life sciences company headquartered in West Jefferson, United States. Its most recent funding round, Growth, raised $49.8M in October 2023.
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $49.8M | — | |
| SEC Form D filing | $100M | — | |
| SEC Form D filing | $80M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of AmplifyBio, LLC's closest competitors — see the full list of competitors and alternatives →
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Andelyn Biosciences is a cell and gene therapy contract development and manufacturing organization (CDMO) that provides viral vector and plasmid manufacturing, process development, and laboratory services.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Shanghai OBiO Technology (Group) Corp., Ltd. is a biotechnology contract development and manufacturing organization (CDMO/CRO) focused on gene and cell therapy services, including viral-vector development and manufacturing. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations developing gene-therapy and related biologics products.
StrataBio Consulting provides strategic consulting, analytical development, laboratory implementation, partner management, and interim leadership services for biotechnology and pharmaceutical companies. The firm helps clients navigate drug development, regulatory compliance, and GMP operations to advance life sciences and advanced therapies.
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about AmplifyBio, LLC? Suggest a correction · Work at AmplifyBio, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.